Abcam, the Cambridge-based producer, distributor and seller of protein research tools, has announced the appointment of Michael Baldock as its Chief Financial Officer (CFO) and Board member, with effect from 3 February 2020. He will take the role from Gavin Wood, who will step down on this date.
Alan Hirzel, CEO of Abcam, commented: “Michael’s expertise will be valuable as we work toward realising our ambition to become the collaborator of choice for the healthcare and life science sector. His energy and passion for our business will fit well with ours and we are pleased to welcome him to Abcam."
Baldock has over 30 years of corporate and financial experience gained through senior leadership roles at HSBC, Lazard, Bentley Health Care and SG Warburg. He is a founding partner at Ondra Partners, an independent financial advisory firm, which has advised Abcam for several years.
Commenting on his appointment, Baldock said: “It is an exciting time to be joining Abcam as it embarks on the next phase of its journey. I am looking forward to working with Alan and the Abcam team, and together implementing the Company’s strategic vision and delivering continued long-term, profitable growth.”
Michael Baldock’s appointment will be subject to receiving the necessary approval from the UK Home Office allowing him to work in the UK.
